Check Out What Whales Are Doing With REGN
Portfolio Pulse from Benzinga Insights
A significant number of investors have taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 70% of detected trades showing bearish expectations. The targeted price range for REGN over the last 3 months is $560.0 to $960.0. The current price of REGN is up 1.0% at $833.48. Major financial institutions such as Wells Fargo, Oppenheimer, Barclays, RBC Capital, and BMO Capital have maintained positive ratings on REGN, with price targets ranging from $830 to $1050.
September 08, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bearish sentiment detected in trades of Regeneron Pharmaceuticals (REGN). The targeted price range is $560-$960. Current price is up 1.0% at $833.48. Major banks maintain positive ratings, with price targets from $830-$1050.
The bearish sentiment detected in the trades indicates a potential short-term decrease in REGN's stock price. However, the positive ratings and high price targets from major banks suggest a positive long-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100